Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel one-step synthesis of quinolines from nitro alcohol and alcohol. Reduces steps, enhances supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104263776A reveals high-yield biocatalytic route for chiral pyridine ethanol offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Novel patent CN114315608B enables cost-effective tri(4-ethynylphenyl)amine production without palladium, ensuring supply chain stability for optoelectronic manufacturers.
Patent CN112125788B reveals a novel ionic liquid catalyzed synthesis for difluoromethyl ether bridged liquid crystal monomers, offering >99.9% purity and >85% yield.
Novel silica-supported catalytic route for benzothiazole derivatives ensures high purity and simplified post-treatment for reliable pharmaceutical intermediate supply chains.
Patent CN105884781B details a chiral catalytic route for Tofacitinib Citrate, offering high purity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Novel Friedel-Crafts method for high-purity pharmaceutical intermediates. Eliminates hydrolysis, reduces cost, ensures scalable supply chain continuity.
Novel synthesis of Cyclopentolate Hydrochloride via CN106083615A ensures high purity and safety. Ideal for reliable ophthalmic API supply chain optimization.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Patent CN119977807B reveals nickel visible light catalysis for aldehyde synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111253406A details a green synthesis route for dihydrobenzo imidazo pyrimidine derivatives using magnetic graphene, offering high purity and recyclable catalysts for reliable pharmaceutical intermediate supply.
Patent CN112279779B details a mild copper-catalyzed asymmetric oxime etherification. Discover high-ee pharmaceutical intermediates and cost-effective manufacturing solutions.
Patent CN106966994A details mild CuTC catalysis for triazoles. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN114716356A details a green Rh-catalyzed route for isothiocyanates, offering safer alternatives to thiophosgene and improved supply chain reliability for fine chemical manufacturing.
Patent CN106978452B reveals ionic liquid modified lipase method for kojic acid ester. Enhances yield and stability for food additive manufacturing supply chains.
Patent CN106567104A reveals a green electrochemical route for 1,1'-diindolylmethane derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113930415A details a novel enzymatic route for antifungal intermediates, offering high stereoselectivity and simplified purification for scalable manufacturing.
Patent CN113444041A details a mild, blue LED-driven route to quinolines. This metal-free process offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.